ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
1000 6 10 6 10 B-lower_bound
/ 10 11 10 11 I-lower_bound
mm^3 11 15 11 15 I-lower_bound
( 16 17 16 17 O
after 17 22 17 22 O
G 23 24 23 24 O
- 24 25 24 25 O
CSF 25 28 25 28 O
discontinued 29 41 29 41 O
) 41 42 41 42 O

Age 0 3 43 46 B-age
greater 4 11 47 54 O
than 12 16 55 59 O
or 17 19 60 62 O
equal 20 25 63 68 O
to 26 28 69 71 O
3 29 30 72 73 B-lower_bound
years 31 36 74 79 I-lower_bound
and 37 40 80 83 O
less 41 45 84 88 O
than 46 50 89 93 O
22 51 53 94 96 O
years 54 59 97 102 O
of 60 62 103 105 O
age 63 66 106 109 B-age
at 67 69 110 112 O
the 70 73 113 116 O
time 74 78 117 121 O
of 79 81 122 124 O
diagnosis 82 91 125 134 O
( 92 93 135 136 O
may 93 96 136 139 O
enroll 97 103 140 146 O
on 104 106 147 149 O
Strata 107 113 150 156 O
W 114 115 157 158 O
, 115 116 158 159 O
S 117 118 160 161 O
or 119 121 162 164 O
N 122 123 165 166 O
) 123 124 166 167 O
, 124 125 167 168 O
OR 126 128 169 171 O
( 129 130 172 173 O
2 130 131 173 174 O
) 131 132 174 175 O
age 133 136 176 179 O
is 137 139 180 182 O
greater 140 147 183 190 O
than 148 152 191 195 O
or 153 155 196 198 O
equal 156 161 199 204 O
to 162 164 205 207 O
22 165 167 208 210 O
years 168 173 211 216 O
and 174 177 217 220 O
less 178 182 221 225 O
than 183 187 226 230 O
40 188 190 231 233 B-upper_bound
years 191 196 234 239 I-upper_bound
AND 197 200 240 243 O
patient 201 208 244 251 O
has 209 212 252 255 O
SHH 213 216 256 259 B-cancer
medulloblastoma 217 232 260 275 I-cancer
( 233 234 276 277 O
must 234 238 277 281 O
enroll 239 245 282 288 O
on 246 248 289 291 O
Stratum 249 256 292 299 O
S 257 258 300 301 O
) 258 259 301 302 O

Alkaline 0 8 303 311 B-clinical_variable
Phosphatase 9 20 312 323 I-clinical_variable
≤ 21 22 324 325 O
1.5X 23 27 326 330 B-upper_bound
the 28 31 331 334 O
institutional 32 45 335 348 B-clinical_variable
ULN 46 49 349 352 I-clinical_variable

BSA 0 3 353 356 B-clinical_variable
must 4 8 357 361 O
be 9 11 362 364 O
> 12 13 365 366 O
0.67 13 17 366 370 B-lower_bound
and 18 21 371 374 O
< 22 23 375 376 O
2.5 23 26 376 379 B-upper_bound
m2 27 29 380 382 I-upper_bound

CNS 0 3 383 386 O
embryonal 4 13 387 396 B-cancer
tumor 14 19 397 402 I-cancer
other 20 25 403 408 O
than 26 30 409 413 O
medulloblastoma 31 46 414 429 B-cancer
or 47 49 430 432 O
PNET 50 54 433 437 B-cancer
in 55 57 438 440 O
the 58 61 441 444 O
posterior 62 71 445 454 O
fossa 72 77 455 460 O

Completed 0 9 461 470 O
protocol 10 18 471 479 O
- 18 19 479 480 O
directed 19 27 480 488 O
radiation 28 37 489 498 B-treatment
therapy 38 45 499 506 I-treatment

English 0 7 507 514 B-language_fluency
as 8 10 515 517 I-language_fluency
primary 11 18 518 525 I-language_fluency
language 19 27 526 534 I-language_fluency
and 28 31 535 538 O
training 32 40 539 547 O
aide 41 45 548 552 O
who 46 49 553 556 O
speaks 50 56 557 563 B-language_fluency
English 57 64 564 571 I-language_fluency
available 65 74 572 581 O
to 75 77 582 584 O
participate 78 89 585 596 O
in 90 92 597 599 O
required 93 101 600 608 O
sessions 102 110 609 617 O

Female 0 6 618 624 B-gender
participants 7 19 625 637 I-gender
> 20 21 638 639 O
10 22 24 640 642 B-lower_bound
years 25 30 643 648 I-lower_bound
of 31 33 649 651 O
age 34 37 652 655 B-age
or 38 40 656 658 O
post 41 45 659 663 O
- 45 46 663 664 O
menarche 46 54 664 672 O
must 55 59 673 677 O
have 60 64 678 682 O
a 65 66 683 684 O
negative 67 75 685 693 B-pregnancy
serum 76 81 694 699 I-pregnancy
or 82 84 700 702 I-pregnancy
urine 85 90 703 708 I-pregnancy
pregnancy 91 100 709 718 I-pregnancy
test 101 105 719 723 O
prior 106 111 724 729 O
to 112 114 730 732 O
enrollment 115 125 733 743 O

Females 0 7 744 751 B-gender
of 8 10 752 754 O
child 11 16 755 760 O
- 16 17 760 761 O
bearing 17 24 761 768 O
potential 25 34 769 778 O
can 35 38 779 782 B-pregnancy
not 38 41 782 785 I-pregnancy
be 42 44 786 788 I-pregnancy
pregnant 45 53 789 797 I-pregnancy

Hgb 0 3 798 801 B-clinical_variable
> 4 5 802 803 O
8 6 7 804 805 B-lower_bound
g 8 9 806 807 I-lower_bound
/ 9 10 807 808 I-lower_bound
dL 10 12 808 810 I-lower_bound
( 13 14 811 812 O
with 14 18 812 816 O
or 19 21 817 819 O
without 22 29 820 827 O
transfusion 30 41 828 839 O
support 42 49 840 847 O
) 49 50 847 848 O

Male 0 4 849 853 B-gender

Medulloblastoma 0 15 854 869 B-cancer
or 16 18 870 872 O
medulloblastoma 19 34 873 888 B-cancer
variants 35 43 889 897 O
including 44 53 898 907 O
posterior 54 63 908 917 B-cancer
fossa 64 69 918 923 I-cancer
PNET 70 74 924 928 I-cancer
as 75 77 929 931 O
documented 78 88 932 942 O
by 89 91 943 945 O
an 92 94 946 948 O
institutional 95 108 949 962 O
pathologist 109 120 963 974 O

Must 0 4 975 979 O
be 5 7 980 982 O
≥ 8 9 983 984 O
5 10 11 985 986 B-lower_bound
years 12 17 987 992 I-lower_bound
and 18 21 993 996 O
< 22 23 997 998 O
22 24 26 999 1001 B-upper_bound
years 27 32 1002 1007 I-upper_bound
at 33 35 1008 1010 O
the 36 39 1011 1014 O
time 40 44 1015 1019 O
of 45 47 1020 1022 O
enrollment 48 58 1023 1033 O

Must 0 4 1034 1038 O
have 5 9 1039 1043 O
no 10 12 1044 1046 O
congenital 13 23 1047 1057 B-chronic_disease
heart 24 29 1058 1063 I-chronic_disease
disease 30 37 1064 1071 I-chronic_disease

No 0 2 1072 1074 O
major 3 8 1075 1080 O
sensory 9 16 1081 1088 B-chronic_disease
or 17 19 1089 1091 I-chronic_disease
motor 20 25 1092 1097 I-chronic_disease
impairment 26 36 1098 1108 I-chronic_disease
that 37 41 1109 1113 O
would 42 47 1114 1119 O
preclude 48 56 1120 1128 O
valid 57 62 1129 1134 O
cognitive 63 72 1135 1144 O
testing 73 80 1145 1152 O
( 81 82 1153 1154 O
e.g. 82 86 1154 1158 O
, 86 87 1158 1159 O
unresolved 88 98 1160 1170 O
posterior 99 108 1171 1180 B-chronic_disease
fossa 109 114 1181 1186 I-chronic_disease
syndrome 115 123 1187 1195 I-chronic_disease
, 123 124 1195 1196 O
blindness 125 134 1197 1206 B-chronic_disease
, 134 135 1206 1207 O
poorly 136 142 1208 1214 O
controlled 143 153 1215 1225 O
seizures 154 162 1226 1234 B-chronic_disease
/ 162 163 1234 1235 O
photosensitive 163 177 1235 1249 B-chronic_disease
epilepsy 178 186 1250 1258 I-chronic_disease
, 186 187 1258 1259 O
psychosis 188 197 1260 1269 B-chronic_disease
) 197 198 1269 1270 O
or 199 201 1271 1273 O
a 202 203 1274 1275 O
major 204 209 1276 1281 O
psychological 210 223 1282 1295 B-chronic_disease
condition 224 233 1296 1305 I-chronic_disease
that 234 238 1306 1310 O
would 239 244 1311 1316 O
preclude 245 253 1317 1325 O
completion 254 264 1326 1336 O
of 265 267 1337 1339 O
the 268 271 1340 1343 O
intervention 272 284 1344 1356 O
( 285 286 1357 1358 O
e.g. 286 290 1358 1362 O
, 290 291 1362 1363 O
significant 292 303 1364 1375 O
oppositionality 304 319 1376 1391 O
, 319 320 1391 1392 O
autism 321 327 1393 1399 B-chronic_disease
spectrum 328 336 1400 1408 I-chronic_disease
disorder 337 345 1409 1417 I-chronic_disease
, 345 346 1417 1418 O
severe 347 353 1419 1425 O
anxiety 354 361 1426 1433 B-chronic_disease
or 362 364 1434 1436 O
depressive 365 375 1437 1447 B-chronic_disease
symptoms 376 384 1448 1456 I-chronic_disease
) 384 385 1456 1457 O

No 0 2 1458 1460 O
previous 3 11 1461 1469 O
radiotherapy 12 24 1470 1482 B-treatment
, 24 25 1482 1483 O
chemotherapy 26 38 1484 1496 B-treatment
or 39 41 1497 1499 O
other 42 47 1500 1505 O
brain 48 53 1506 1511 B-cancer
tumor 54 59 1512 1517 I-cancer
directed 60 68 1518 1526 O
therapy 69 76 1527 1534 O
other 77 82 1535 1540 O
than 83 87 1541 1545 O
corticosteroid 88 102 1546 1560 B-treatment
therapy 103 110 1561 1568 I-treatment
and 111 114 1569 1572 O
surgery 115 122 1573 1580 B-treatment

No 0 2 1581 1583 O
significant 3 14 1584 1595 O
cognitive 15 24 1596 1605 B-chronic_disease
impairment 25 35 1606 1616 I-chronic_disease
operationalized 36 51 1617 1632 O
as 52 54 1633 1635 O
either 55 61 1636 1642 O
an 62 64 1643 1645 O
IQ 65 67 1646 1648 B-clinical_variable
< 68 69 1649 1650 O
70 70 72 1651 1653 B-upper_bound
for 73 76 1654 1657 O
children 77 85 1658 1666 O
with 86 90 1667 1671 O
St. 91 94 1672 1675 O
Jude 95 99 1676 1680 O
SJMB12 100 106 1681 1687 B-clinical_variable
study 107 112 1688 1693 O
baseline 113 121 1694 1702 O
testing 122 129 1703 1710 O
or 130 132 1711 1713 O
based 133 138 1714 1719 O
on 139 141 1720 1722 O
clinician 142 151 1723 1732 O
judgment 152 160 1733 1741 O
baseline 161 169 1742 1750 O
IQ 170 172 1751 1753 O
missing 173 180 1754 1761 O

Participants 0 12 1762 1774 O
must 13 17 1775 1779 O
be 18 20 1780 1782 O
skeletally 21 31 1783 1793 O
mature 32 38 1794 1800 O
defined 39 46 1801 1808 O
as 47 49 1809 1811 O
females 50 57 1812 1819 B-gender
with 58 62 1820 1824 O
a 63 64 1825 1826 O
bone 65 69 1827 1831 O
age 70 73 1832 1835 O
≥ 74 75 1836 1837 O
15 76 78 1838 1840 B-lower_bound
years 79 84 1841 1846 I-lower_bound
and 85 88 1847 1850 O
males 89 94 1851 1856 O
with 95 99 1857 1861 O
a 100 101 1862 1863 O
bone 102 106 1864 1868 O
age 107 110 1869 1872 O
≥ 111 112 1873 1874 O
17 113 115 1875 1877 B-lower_bound
years 116 121 1878 1883 I-lower_bound

Patients 0 8 1884 1892 O
must 9 13 1893 1897 O
begin 14 19 1898 1903 O
treatment 20 29 1904 1913 B-treatment
as 30 32 1914 1916 O
outlined 33 41 1917 1925 O
in 42 44 1926 1928 O
the 45 48 1929 1932 O
protocol 49 57 1933 1941 O
within 58 64 1942 1948 O
36 65 67 1949 1951 B-upper_bound
days 68 72 1952 1956 I-upper_bound
of 73 75 1957 1959 O
definitive 76 86 1960 1970 B-treatment
surgery 87 94 1971 1978 I-treatment
( 95 96 1979 1980 O
day 96 99 1980 1983 O
of 100 102 1984 1986 O
surgery 103 110 1987 1994 O
is 111 113 1995 1997 O
day 114 117 1998 2001 O
0 118 119 2002 2003 O
; 119 120 2003 2004 O
definitive 121 131 2005 2015 O
surgery 132 139 2016 2023 O
includes 140 148 2024 2032 O
second 149 155 2033 2039 O
surgeries 156 165 2040 2049 B-treatment
to 166 168 2050 2052 O
resect 169 175 2053 2059 O
residual 176 184 2060 2068 O
tumor 185 190 2069 2074 B-cancer
) 190 191 2074 2075 O

Platelets 0 9 2076 2085 B-clinical_variable
> 10 11 2086 2087 O
50,000 12 18 2088 2094 B-lower_bound
/ 18 19 2094 2095 I-lower_bound
mm^3 19 23 2095 2099 I-lower_bound
( 24 25 2100 2101 O
without 25 32 2101 2108 O
support 33 40 2109 2116 O
) 40 41 2116 2117 O

Research 0 8 2118 2126 O
participants 9 21 2127 2139 O
with 22 26 2140 2144 O
other 27 32 2145 2150 O
clinically 33 43 2151 2161 O
significant 44 55 2162 2173 O
medical 56 63 2174 2181 B-chronic_disease
disorders 64 73 2182 2191 I-chronic_disease
that 74 78 2192 2196 O
could 79 84 2197 2202 O
compromise 85 95 2203 2213 O
their 96 101 2214 2219 O
ability 102 109 2220 2227 O
to 110 112 2228 2230 O
tolerate 113 121 2231 2239 O
protocol 122 130 2240 2248 O
therapy 131 138 2249 2256 B-treatment
or 139 141 2257 2259 O
would 142 147 2260 2265 O
interfere 148 157 2266 2275 O
with 158 162 2276 2280 O
the 163 166 2281 2284 O
study 167 172 2285 2290 O
procedures 173 183 2291 2301 O
or 184 186 2302 2304 O
results 187 194 2305 2312 O
history 195 202 2313 2320 O

SGOT 0 4 2321 2325 B-clinical_variable
( 5 6 2326 2327 I-clinical_variable
AST 6 9 2327 2330 I-clinical_variable
) 9 10 2330 2331 I-clinical_variable
≤ 11 12 2332 2333 O
2.5X 13 17 2334 2338 B-upper_bound
the 18 21 2339 2342 I-upper_bound
institutional 22 35 2343 2356 I-upper_bound
ULN 36 39 2357 2360 I-upper_bound

SGPT 0 4 2361 2365 B-clinical_variable
( 5 6 2366 2367 O
ALT 6 9 2367 2370 B-clinical_variable
) 9 10 2370 2371 O
≤ 11 12 2372 2373 O
2.5X 13 17 2374 2378 B-upper_bound
the 18 21 2379 2382 I-upper_bound
institutional 22 35 2383 2396 I-upper_bound
ULN 36 39 2397 2400 I-upper_bound

Serum 0 5 2401 2406 B-clinical_variable
creatinine 6 16 2407 2417 I-clinical_variable
≤ 17 18 2418 2419 O
1.5 19 22 2420 2423 B-upper_bound
mg 23 25 2424 2426 I-upper_bound
/ 25 26 2426 2427 I-upper_bound
dL 26 28 2427 2429 I-upper_bound

Total 0 5 2430 2435 O
bilirubin 6 15 2436 2445 B-clinical_variable
≤ 16 17 2446 2447 O
1.5X 18 22 2448 2452 B-upper_bound
the 23 26 2453 2456 I-upper_bound
institutional 27 40 2457 2470 I-upper_bound
ULN 41 44 2471 2474 I-upper_bound

children 0 8 2475 2483 B-clinical_variable
< 9 10 2484 2485 O
10 11 13 2486 2488 O
- 13 14 2488 2489 O
Lansky 14 20 2489 2495 B-clinical_variable
Score 21 26 2496 2501 I-clinical_variable
≥ 27 28 2502 2503 O
30 29 31 2504 2506 B-lower_bound
; 31 32 2506 2507 O
children 33 41 2508 2516 O
≥ 42 43 2517 2518 O
10 44 46 2519 2521 O
- 46 47 2521 2522 O
Karnofsky 47 56 2522 2531 B-clinical_variable
≥ 57 58 2532 2533 O
30 59 61 2534 2536 O

except 0 6 2537 2543 O
for 7 10 2544 2547 O
posterior 11 20 2548 2557 B-chronic_disease
fossa 21 26 2558 2563 I-chronic_disease
syndrome 27 35 2564 2572 I-chronic_disease

female 0 6 2573 2579 B-treatment
participants 7 19 2580 2592 I-treatment
of 20 22 2593 2595 O
reproductive 23 35 2596 2608 O
potential 36 45 2609 2618 O
must 46 50 2619 2623 O
agree 51 56 2624 2629 B-contraception_consent
to 57 59 2630 2632 I-contraception_consent
effective 60 69 2633 2642 I-contraception_consent
contraception 70 83 2643 2656 I-contraception_consent
during 84 90 2657 2663 O
and 91 94 2664 2667 O
after 95 100 2668 2673 O
study 101 106 2674 2679 O
treatment 107 116 2680 2689 B-treatment

≥5 0 2 2690 2692 O
years 3 8 2693 2698 I-lower_bound
at 9 11 2699 2701 O
the 12 15 2702 2705 O
time 16 20 2706 2710 O
of 21 23 2711 2713 O
remediation 24 35 2714 2725 O
intervention 36 48 2726 2738 O
consent 49 56 2739 2746 O
or 57 59 2747 2749 O
age 60 63 2750 2753 B-age
is 64 66 2754 2756 O
greater 67 74 2757 2764 O
than 75 79 2765 2769 O
or 80 82 2770 2772 O
equal 83 88 2773 2778 O
to 89 91 2779 2781 O
22 92 94 2782 2784 B-lower_bound
years 95 100 2785 2790 I-lower_bound
and 101 104 2791 2794 O
less 105 109 2795 2799 O
than 110 114 2800 2804 O
40 115 117 2805 2807 B-upper_bound
years 118 123 2808 2813 I-upper_bound
and 124 127 2814 2817 O
patient 128 135 2818 2825 O
has 136 139 2826 2829 O
SHH 140 143 2830 2833 B-cancer
medulloblastoma 144 159 2834 2849 I-cancer

